Cargando…
c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689795/ https://www.ncbi.nlm.nih.gov/pubmed/31496808 http://dx.doi.org/10.2147/CMAR.S225782 |
Ejemplares similares
-
c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients
por: Lin, Shu-Hui, et al.
Publicado: (2019) -
Corrigendum to “Clinical Significance of the Decreased Expression of hsa_circ_001242 in Oral Squamous Cell Carcinoma”
por: Sun, Shuai, et al.
Publicado: (2019) -
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
por: Shao, Yuan, et al.
Publicado: (2013) -
Corrigendum to “Anticancer Effects of Salvia miltiorrhiza Alcohol Extract on Oral Squamous Carcinoma Cells”
por: Wang, Wen-Hung, et al.
Publicado: (2017) -
Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2021)